Thrombophilia prevalence varies: in Whites, factor V Leiden mutation accounts for 5% and prothrombin mutation accounts for 3%; lupus anticoagulants are found in up to 5% of individuals, whereas decreased protein C, protein S, and antithrombin activity occurs in less than 0.5% of cases [9]. This evidence concerns the gene F2 and Rare hereditary thrombophilia.